[go: up one dir, main page]

FI20000976L - Tuotteita - Google Patents

Tuotteita Download PDF

Info

Publication number
FI20000976L
FI20000976L FI20000976A FI20000976A FI20000976L FI 20000976 L FI20000976 L FI 20000976L FI 20000976 A FI20000976 A FI 20000976A FI 20000976 A FI20000976 A FI 20000976A FI 20000976 L FI20000976 L FI 20000976L
Authority
FI
Finland
Prior art keywords
products
Prior art date
Application number
FI20000976A
Other languages
English (en)
Swedish (sv)
Other versions
FI20000976A0 (fi
FI20000976A7 (fi
Inventor
Jeffrey Emmick
Kenneth Ferguson
William Pullman
John Whitaker
Original Assignee
Lilly Icos Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22452153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI20000976(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc
Publication of FI20000976A0 publication Critical patent/FI20000976A0/fi
Publication of FI20000976A7 publication Critical patent/FI20000976A7/fi
Publication of FI20000976L publication Critical patent/FI20000976L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI20000976A 1999-04-30 2000-04-26 Tuotteita FI20000976L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13203699P 1999-04-30 1999-04-30

Publications (3)

Publication Number Publication Date
FI20000976A0 FI20000976A0 (fi) 2000-04-26
FI20000976A7 FI20000976A7 (fi) 2000-10-30
FI20000976L true FI20000976L (fi) 2000-10-30

Family

ID=22452153

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20000976A FI20000976L (fi) 1999-04-30 2000-04-26 Tuotteita

Country Status (47)

Country Link
EP (2) EP1415652A3 (fi)
JP (2) JP4975214B2 (fi)
KR (2) KR20010020779A (fi)
CN (2) CN1196487C (fi)
AT (1) ATE251908T1 (fi)
AU (3) AU769946C (fi)
BE (1) BE1012957A5 (fi)
BR (2) BR0003046A (fi)
CA (2) CA2307101C (fi)
CH (2) CH692478A5 (fi)
CO (1) CO5170493A1 (fi)
CZ (1) CZ296534B6 (fi)
DE (3) DE10021266A1 (fi)
DK (2) DK1173181T6 (fi)
DZ (1) DZ3171A1 (fi)
EA (2) EA005416B1 (fi)
ES (2) ES2187234A1 (fi)
FI (1) FI20000976L (fi)
FR (1) FR2795646B1 (fi)
GB (1) GB2351663A (fi)
GR (1) GR1003575B (fi)
HK (1) HK1041204B (fi)
HR (2) HRP20000243A2 (fi)
HU (2) HUP0001632A3 (fi)
ID (1) ID25704A (fi)
IE (1) IE20000315A1 (fi)
IL (3) IL135817A0 (fi)
IT (1) ITMI20000922A1 (fi)
LT (1) LT4758B (fi)
LU (1) LU90569B1 (fi)
LV (1) LV12560B (fi)
MX (2) MXPA00003997A (fi)
NL (1) NL1015027C2 (fi)
NO (2) NO20002097L (fi)
NZ (2) NZ504163A (fi)
PE (1) PE20010071A1 (fi)
PL (2) PL197813B1 (fi)
PT (2) PT102457A (fi)
SE (1) SE0001518L (fi)
SG (1) SG98384A1 (fi)
SI (2) SI20361A (fi)
SK (1) SK285415B6 (fi)
SV (1) SV2002000055A (fi)
TR (1) TR200001132A3 (fi)
UA (1) UA72248C2 (fi)
WO (1) WO2000066099A2 (fi)
ZA (2) ZA200002058B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287869B6 (sk) * 1999-08-03 2012-02-03 Icos Corporation Beta-carboline pharmaceutical compositions
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
US20030153575A1 (en) * 2000-06-08 2003-08-14 Orme Mark W. Tetracyclic diketopiperazine compounds as pdev inhibitors
AU2001271948A1 (en) * 2000-08-02 2002-02-13 Lilly Icos Llc Fused heterocyclic derivatives as phosphodiesterase inhibitors
WO2002098428A1 (en) * 2001-06-05 2002-12-12 Lilly Icos Llc Tetracyclic compounds as pde5-inhibitors
GB0129274D0 (en) * 2001-12-06 2002-01-23 Pfizer Ltd Novel kit
US20060205733A1 (en) * 2004-08-26 2006-09-14 Encysive Pharmaceuticals Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
KR20080112285A (ko) * 2006-03-28 2008-12-24 자블린 파머슈티칼스 인코포레이티드 저 복용량의 디클로페낙 및 베타-사이클로덱스트린 제형
US7495024B2 (en) 2006-08-07 2009-02-24 Via Pharmaceuticals, Inc. Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
DE102007028869A1 (de) 2007-06-22 2008-12-24 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
DE102009033396A1 (de) 2009-07-16 2011-01-20 Ratiopharm Gmbh Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung
US20110136815A1 (en) 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
US20110263606A1 (en) * 2010-04-26 2011-10-27 Horst Zerbe Solid oral dosage forms comprising tadalafil
RU2013141446A (ru) 2011-02-10 2015-03-20 Синтон Бв Фармацевтическая композиция, содержащая тадалафил и циклодекстрин
WO2012107092A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
EP2672959A1 (en) 2011-02-10 2013-12-18 Synthon BV Granulated composition comprising tadalafil and a disintegrant
KR102239291B1 (ko) 2013-06-28 2021-04-14 한미약품 주식회사 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
KR20150056443A (ko) 2013-11-15 2015-05-26 한미약품 주식회사 타다라필 및 암로디핀을 포함하는 복합제제
JP2019065006A (ja) 2017-09-29 2019-04-25 ハンミ ファーマシューティカルズ カンパニー リミテッド 生産性及び均一性が改善されたタダラフィルを含む固形製剤、及びその製造方法
EP3749370B1 (de) * 2018-02-07 2025-05-07 Smawa GmbH Pharmazeutische formulierungen, verfahren zum herstellen einer pharmazeutischen formulierung sowie ein arzneimittel umfassend eine solche

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9514465D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9401090D0 (en) * 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9511220D0 (en) * 1995-06-02 1995-07-26 Glaxo Group Ltd Solid dispersions
GB9514473D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
GB9514464D0 (en) * 1995-07-14 1995-09-13 Glaxo Lab Sa Medicaments
YU49898A (sh) 1996-05-10 2000-03-21 Icos Corporation Hemijska jedinjenja
EA002057B1 (ru) * 1997-04-25 2001-12-24 Пфайзер Инк. ПИРАЗОЛОПИРИМИДИНОНЫ, КОТОРЫЕ ИНГИБИРУЮТ ЦИКЛИЧЕСКИЙ ГУАНОЗИН-3',5'-МОНОФОСФАТ-ФОСФОДИЭСТЕРАЗУ ТИПА 5 (cGMP PDE5), ДЛЯ ЛЕЧЕНИЯ СЕКСУАЛЬНОГО РАССТРОЙСТВА
WO1999059584A1 (en) * 1998-05-20 1999-11-25 Schering Corporation Combination of phentolamine and cyclic gmp phosphodiesterase inhibitors for the treatment of sexual dysfunction
EP1114048A1 (en) 1998-09-16 2001-07-11 Agnès Bombrun Carboline derivatives as cgmp phosphodiesterase inhibitors
US6743443B1 (en) * 1998-10-05 2004-06-01 Eisai Co., Ltd. Tablets immediately disintegrating in the oral cavity
AU3724400A (en) * 1999-03-08 2000-09-28 Merck & Co., Inc. Methods and compositions for treating erectile dysfunction
JP2002543128A (ja) * 1999-04-30 2002-12-17 リリー アイコス リミテッド ライアビリティ カンパニー 雌性覚醒障害の処置
US6451807B1 (en) * 1999-04-30 2002-09-17 Lilly Icos, Llc. Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor

Also Published As

Publication number Publication date
CA2371684A1 (en) 2000-11-09
HRP20000243A2 (en) 2001-12-31
GR1003575B (el) 2001-05-14
NO322013B1 (no) 2006-08-07
DE10021266A1 (de) 2000-11-16
DE60005940D1 (de) 2003-11-20
FI20000976A0 (fi) 2000-04-26
SI20361A (sl) 2001-04-30
PL339897A1 (en) 2000-11-06
CH1173181H1 (fi) 2019-07-15
EP1173181B3 (en) 2015-03-25
AU4490800A (en) 2000-11-17
DK1173181T6 (en) 2015-04-27
TR200001132A2 (tr) 2001-01-22
DE60005940T3 (de) 2015-08-27
AU3012900A (en) 2000-11-02
EP1415652A3 (en) 2004-05-12
PT1173181E (pt) 2004-02-27
EP1173181B1 (en) 2003-10-15
NO20015275D0 (no) 2001-10-29
IL146098A (en) 2007-06-03
SI1173181T1 (en) 2004-04-30
HUP0200912A3 (en) 2003-07-28
ES2208317T3 (es) 2004-06-16
DK200000677A (da) 2000-10-31
MXPA01010837A (es) 2002-11-07
CA2307101C (en) 2003-01-28
EA200101008A1 (ru) 2002-04-25
EP1173181A2 (en) 2002-01-23
FR2795646A1 (fr) 2001-01-05
SV2002000055A (es) 2002-07-03
UA72248C2 (en) 2005-02-15
SG98384A1 (en) 2003-09-19
HUP0001632A2 (hu) 2001-05-28
FI20000976A7 (fi) 2000-10-30
CA2371684C (en) 2007-10-23
WO2000066099A3 (en) 2001-01-18
CN1384746A (zh) 2002-12-11
JP2000336043A (ja) 2000-12-05
NL1015027C2 (nl) 2001-02-14
MXPA00003997A (es) 2002-03-08
NL1015027A1 (nl) 2000-10-31
HK1041204A1 (en) 2002-07-05
HRP20010778A2 (en) 2002-12-31
PL197813B1 (pl) 2008-04-30
SE0001518L (sv) 2000-10-31
ID25704A (id) 2000-11-02
ZA200002058B (en) 2000-11-02
ZA200108900B (en) 2003-03-26
KR100577057B1 (ko) 2006-05-10
HU0001632D0 (en) 2000-06-28
SE0001518D0 (sv) 2000-04-26
PL352629A1 (en) 2003-08-25
BR0010181A (pt) 2003-02-25
JP4975214B2 (ja) 2012-07-11
LV12560B (en) 2001-04-20
SK285415B6 (sk) 2007-01-04
LT4758B (lt) 2001-02-26
EA200000355A3 (ru) 2001-02-26
IL135817A0 (en) 2001-05-20
HUP0200912A2 (en) 2002-08-28
LT2000035A (lt) 2000-11-27
CH692478A5 (de) 2002-07-15
BE1012957A5 (fr) 2001-06-05
KR20010020779A (ko) 2001-03-15
NZ514882A (en) 2003-08-29
NO20002097D0 (no) 2000-04-25
ITMI20000922A1 (it) 2001-10-26
LV12560A (en) 2000-11-20
CO5170493A1 (es) 2002-06-27
AU769946C (en) 2005-01-13
NO20015275L (no) 2001-12-06
CZ296534B6 (cs) 2006-04-12
LU90569B1 (fr) 2002-02-27
NZ504163A (en) 2001-11-30
CN1292264A (zh) 2001-04-25
FR2795646B1 (fr) 2002-08-16
AU2004201988A1 (en) 2004-06-10
CZ20013879A3 (cs) 2002-04-17
NO20002097L (no) 2001-10-26
ES2187234A1 (es) 2003-05-16
GB0010199D0 (en) 2000-06-14
GB2351663A (en) 2001-01-10
KR20020008396A (ko) 2002-01-30
GR20000100153A (el) 2000-12-29
TR200001132A3 (tr) 2001-01-22
HUP0001632A3 (en) 2001-12-28
IL146098A0 (en) 2002-07-25
HU0200912D0 (en) 2002-04-29
CN1196487C (zh) 2005-04-13
PE20010071A1 (es) 2001-03-22
ES2208317T7 (es) 2015-09-15
BR0003046A (pt) 2002-07-23
NO322013B3 (no) 2017-11-06
JP2002543116A (ja) 2002-12-17
HRP20010778B1 (en) 2005-04-30
PT102457A (pt) 2000-11-30
EA200000355A2 (ru) 2000-10-30
DZ3171A1 (fi) 2000-11-09
IE20000315A1 (en) 2001-03-07
CA2307101A1 (en) 2000-10-30
HU230369B1 (hu) 2016-03-29
WO2000066099A2 (en) 2000-11-09
EA005416B1 (ru) 2005-02-24
ATE251908T1 (de) 2003-11-15
ITMI20000922A0 (it) 2000-04-26
SK15632001A3 (sk) 2002-02-05
DK1173181T3 (da) 2004-02-16
AU769946B2 (en) 2004-02-12
DE20007861U1 (de) 2000-08-24
HK1041204B (en) 2004-03-05
DE60005940T2 (de) 2004-07-29
EP1415652A2 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
DE122007000064I2 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
DE50002834D1 (de) Handstempel
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
FI20000976L (fi) Tuotteita
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE50009570D1 (de) Wechselcorrugator
DE50007953D1 (de) Beleuchtungsanordung
DE50000805D1 (de) Aufsitzspanner
DE50006899D1 (de) Antistatikum
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE50012482D1 (de) Tibiamarknagel
DE50003259D1 (de) Textilie
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
DE50008429D1 (de) Kraftstofffraktioniereinrichtung
DE50006759D1 (de) Piperidinalkohole
ATE440824T1 (de) Nitro-sulfobenzamide
DE50009208D1 (de) Hydroxyphenylvinylthiazole
DE50006829D1 (de) Benzoylpyridazine
DE10082008D2 (de) Ausbeulgerät
DE50003283D1 (de) Exzenterspannzwinge
ATA107599A (de) Heizwasserbereiter
DE50009073D1 (de) Säkombination

Legal Events

Date Code Title Description
MA Patent expired